GlassScriptPhysician profile
Melissa L Adams
NPI 1285801282
$5,595.77
in general payments reported to CMS, 2019-2025
20 companies · $539 in 2025
The $539 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,089 · 2020: $237 · 2021: $17.20 · 2022: $3,435 · 2023: $250 · 2024: $29.06 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749 · Travel and Lodging: $69.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.78 |
| Travel and Lodging | $69.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,870.40 | 2022 | |
| Pylant Medical | $1,581.27 | 2019-2025 | |
| Stryker Corporation | $189.65 | 2022-2025 | Actishield, Augment Injectable, Dart-Fire |
| Treace Medical Concepts, INC. | $151.93 | 2022-2023 | |
| Integra Lifesciences Corporation | $135.39 | 2020 | |
| Horizon Therapeutics Plc | $116.66 | 2023 | Krystexxa |
| Organogenesis INC. | $114.48 | 2019-2023 | Puraply |
| Paragon 28, INC. | $109.21 | 2025 | Portfolio |
| Fusion Orthopedics USA, LLC | $87.27 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $44.29 | 2023-2024 | Breztri |
| Depuy Synthes Sales INC. | $31.03 | 2022 | |
| Sumitomo Pharma America, INC. | $27.65 | 2025 | Gemtesa |
| Lundbeck LLC | $24.47 | 2025 | Rexulti |
| Bioventus LLC | $20.67 | 2025 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $19.50 | 2023 | Nuzyra |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.45 | 2023 | Repatha, Otezla |
| Exact Sciences Corporation | $15.17 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $15.09 | 2025 | Zepbound, Mounjaro |
| Kerecis Limited | $15.06 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Kci USA, INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.